PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH) Financial Statements (2024 and earlier)
Company Profile
Business Address |
5910 SOUTH UNIVERSITY BLVD GREENWOOD VILLAGE, CO 80121 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 116 | 1,114 | 3,811 | 25 | 18 | 2 | |||
Cash and cash equivalents | 101 | 7 | 20 | 25 | 18 | 2 | |||
Short-term investments | 15 | 1,107 | 3,791 | ||||||
Receivables | 264 | 206 | 744 | 75 | |||||
Inventory, net of allowances, customer advances and progress billings | 4,014 | 4,449 | 4,264 | 11 | 1,338 | ||||
Inventory | 4,014 | 4,449 | 4,264 | 11 | 1,338 | ||||
Prepaid expense | 12 | ||||||||
Other undisclosed current assets | 263 | 613 | 278 | 15 | 998 | ||||
Total current assets: | 4,656 | 6,382 | 9,098 | 51 | 2,429 | 14 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 3,865 | 3,242 | 3,595 | 2,173 | ✕ | ||||
Property, plant and equipment | 6,448 | 7,676 | 8,840 | 20 | 477 | ||||
Intangible assets, net (including goodwill) | 3,014 | 2,189 | 2,250 | 2,147 | |||||
Goodwill | 3,014 | 2,189 | 2,189 | ||||||
Intangible assets, net (excluding goodwill) | 61 | 2,147 | |||||||
Other undisclosed noncurrent assets | 2,572 | ||||||||
Total noncurrent assets: | 13,327 | 13,107 | 14,685 | 20 | 7,370 | ||||
TOTAL ASSETS: | 17,983 | 19,489 | 23,784 | 71 | 9,799 | 14 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 4,630 | 2,666 | 1,686 | 2,700 | 1,817 | 1,037 | |||
Interest and dividends payable | ✕ | ✕ | ✕ | 52 | 17 | 66 | |||
Accounts payable | 2,028 | 1,442 | 923 | ||||||
Accrued liabilities | 620 | 358 | 47 | ||||||
Other undisclosed accounts payable and accrued liabilities | 4,630 | 2,666 | 1,686 | ||||||
Deferred revenue | 215 | ✕ | |||||||
Debt | 347 | 220 | 696 | 518 | 492 | ||||
Derivative instruments and hedges, liabilities | 237 | 880 | 1,742 | ||||||
Due to related parties | ✕ | ✕ | 9,872 | 6,442 | 50 | 510 | |||
Other undisclosed current liabilities | 14,818 | 2,189 | 1,723 | 1,221 | 250 | 68 | |||
Total current liabilities: | 19,448 | 15,074 | 10,071 | 4,905 | 4,191 | 3,339 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 3,347 | 205 | 1,927 | 100 | |||||
Long-term debt, excluding current maturities | 205 | 100 | 100 | ||||||
Liabilities, other than long-term debt | 6,827 | 6,560 | 3,263 | ||||||
Due to related parties | ✕ | ✕ | 3,573 | 3,263 | |||||
Other liabilities | 3,573 | ||||||||
Operating lease, liability | 3,254 | 2,987 | 3,347 | 1,827 | ✕ | ||||
Total noncurrent liabilities: | 6,827 | 6,560 | 6,610 | 205 | 1,927 | 100 | |||
Total liabilities: | 26,275 | 21,634 | 16,681 | 5,110 | 6,117 | 3,439 | |||
Equity | |||||||||
Equity, attributable to parent, including: | (8,291) | (2,145) | 7,102 | (3,258) | 4,219 | (3,425) | |||
Common stock | 2 | 1 | 1 | 6 | 4 | 1 | |||
Common stock, share subscribed but unissued, subscriptions receivable | (0) | (0) | |||||||
Additional paid in capital | 25,628 | 23,761 | 23,865 | 27,486 | 25,343 | 7,111 | |||
Accumulated deficit | (33,923) | (25,908) | (16,765) | (30,384) | (21,129) | (10,538) | |||
Other undisclosed equity, attributable to parent | 1 | 1 | 1 | (365) | 1 | 1 | |||
Equity, attributable to noncontrolling interest | (2,018) | (537) | |||||||
Other undisclosed equity | 238 | ||||||||
Total equity: | (8,291) | (2,145) | 7,102 | (5,039) | 3,682 | (3,425) | |||
TOTAL LIABILITIES AND EQUITY: | 17,983 | 19,489 | 23,784 | 71 | 9,799 | 14 |
Income Statement (P&L) ($ in thousands)
3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2,385 | 1,627 | 2,060 | 2,071 | 346 | |||
Loss on disposition of assets for financial service operations | (539) | (297) | ||||||
Cost of revenue | (1,263) | (1,231) | (1,519) | (2,302) | (1,939) | |||
Cost of goods and services sold | (2,720) | (2,046) | ||||||
Other undisclosed gross profit | (418) | (107) | ||||||
Gross profit: | 1,122 | 396 | 541 | (649) | (1,700) | |||
Operating expenses | (6,668) | (6,049) | (6,478) | (9,906) | (9,178) | (2,436) | ||
Operating loss: | (5,546) | (5,652) | (5,937) | (10,555) | (10,878) | (2,436) | ||
Nonoperating income (expense) | (2,469) | (3,490) | 1,155 | (387) | 654 | (1,901) | ||
Investment income, nonoperating | 178 | 232 | 237 | |||||
Other nonoperating income (expense) | (387) | 654 | (1,901) | |||||
Interest and debt expense | 1 | 682 | 756 | 126 | 3,005 | (464) | ||
Loss from continuing operations before equity method investments, income taxes: | (8,015) | (8,461) | (4,027) | (10,815) | (7,220) | (4,802) | ||
Other undisclosed income (loss) from continuing operations before income taxes | (1) | (682) | (756) | (126) | (3,005) | 464 | ||
Loss from continuing operations: | (8,015) | (9,143) | (4,782) | (10,941) | (10,225) | (4,337) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (4,782) | (10,941) | (10,225) | (4,337) | |
Net loss attributable to parent: | (8,015) | (9,143) | (4,782) | (10,941) | (10,225) | (4,337) | ||
Preferred stock dividends and other adjustments | (904) | |||||||
Other undisclosed net income available to common stockholders, basic | 1,481 | 537 | ||||||
Net loss available to common stockholders, diluted: | (8,015) | (9,143) | (4,782) | (9,461) | (10,591) | (4,337) |
Comprehensive Income ($ in thousands)
3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (8,015) | (9,143) | (4,782) | (10,941) | (10,225) | (4,337) | ||
Comprehensive loss, net of tax, attributable to parent: | (8,015) | (9,143) | (4,782) | (10,941) | (10,225) | (4,337) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.